Tysabri - Linked to Progressive Multifocal Leukoencephalopathy (PML)
Tysabri, a drug used for treatment for multiple sclerosis made by Biogen Idec and Elan. Tysabri helps to prevent episodes of symptoms and slow the worsening of disability in patients with relapsing forms (course of disease where symptoms flare up from time to time) of multiple sclerosis (MS). Per recent medical studies, Tysabri is linked to causing a serious brain infection called progressive multifocal leukoencephalopathy, or PML. According to the FDA, the longer Tysabri is used, the higher the risk for contracting PML. PML attacks the brain and central nervous system and is usually fatal. Symptoms include vision problems, loss of coordination, and memory loss. Patients who survive the disease are often permanently disabled. In Feb. 2011 the FDA reported that 102 cases of Tysabri PML have been reported among 82,732 patients treated with Tysabri use worldwide. Later in 2011, the FDA issued new Tysabri Gudielines to Heathcare Professionals. (See:Tysabri PML Dear Doctor Letter- April 20, 2011)
Tysabri Touch Program
A Tysabri patient can only receive a tysabri / natalizumab injection if they are registered with the Tysabri TOUCH program, and the natalizumab is prescribed by a doctor who is registered with the Touch Program and the Tysabri infusion is only administered at a Touch Program approved and registered infusion center.
Tysabri Recall Update
In the U.S. Tysabri was taken off the market in 2005 after three patients in clinical trials developed PML. Later Tysabri was reapproved in 2006, in spite of the PML risk, but with additional PML warnings. (See:Tysabri Recall / Withdrawal)
Free Tysabri PML Case Evaluation Form or Call Nationwide Toll Free 1-800-468-4878
Tysabri Side Effects
According to medical reports, Tysabri / Natalizumab may cause serious allergic reactions that are most likely to happen within 2 hours after the beginning of an infusion, but may happen at any time during the Tysabri infusion treatment. Tysabri patients are required to stay at the infusion center for 1 hour after their infusion is finished. A doctor or nurse monitors the Tysabri patient during this time to see if you are having a serious reaction to the medication. It is very important that the Tysabri patient tell the doctors if they experience any unusual symptoms especially if they occur within 2 hours after the start of your infusion.
Early Signs of PML:
Typical symptoms associated with PML progress quickly over days to weeks, and can include:
- Tysabri Patient has personality or behavioral changes
- Changes in thinking, memory, and orientation leading to confusion to Tysabri user
- Tysabri patient has onset of seizures, clumsiness or progressive weakness on one side of the body
- Tysabri patient has change of vision or "disturbances of vision"
* See Tysabri PML Symptoms for more information
Tysabri PML Lawsuit - Talk to a Tysabri Attorney
If you or a loved one have taken Tysabri and been later diagnosed with progressive multifocal leukoencephalopathy, or PML, then call and talk to a lawyer about what legal options may be available to you and your family. Call us even if Tysabri patient signed paper worked with the TOUCH PROGRAM.
Call for a Free & Confidential Tysabri Lawsuit Evaluation. Talk to a Board Certified Personal Injury Trial Lawyer licensed in Texas and in New York with a National Presence with the Highest Peer Review Rating. All cases are taken on a contingency fee basis and the client is never charged an attorney fee or any legal case expenses unless a recovery is obtained. We are currently handling other Tysabri PML cases and understand the dangerous nature of this product and the devastating effects of Progressive Multifocal Leukoencephalopathy (PML) on the victim and the family.
Tysabri PML Lawsuit - Free Lawyer Consultation
(All Responses Kept Confidential).
